Novartis, the world’s fourth- largest pharmaceutical firm, has
hired Greenlines Healthcare Communications to work on the communications
strategy for its Alzheimer’s disease treatment Exelon.
Greenlines replaces incumbent The Workhouse on the account which was
awarded following a three-way competitive pitch. Board director Ina
Chandler-Brown will head the account for Greenlines, reporting to Exelon
product manager Linda Cockinis; and to Kate Scott, marketing manager,
central nervous system.
Greenlines will target UK healthcare professionals disseminating
clinical data. It will also target the media. The drug is due to go
before the National Institute of Clinical Excellence between July and
December this year, but Greenlines is not involved in that submission.